Individualized COPD therapy may reduce exacerbations, costs
from Pharmacy Times
Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death by disease in the U.S. COPD is one of the most prevalent chronic diseases associated with lifelong economic burden without a cure. As the disease progresses, patients can experience exacerbations leading to a decreased quality of life, and increased costs.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063